Melexis (MELE) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
13 Apr, 2026Executive summary
Full year 2025 sales reached EUR 839.6 million, down 10% year-over-year, with Q4 sales at EUR 214.5 million, up 9% year-over-year but flat sequentially.
Net income for 2025 was EUR 112.5 million (EUR 2.78/share), down 34% year-over-year; Q4 net income was EUR 22.6 million (EUR 0.56/share), up 24% year-over-year but down 18% sequentially.
APAC, especially China, drove growth with record Q4 sales, while Europe and the Americas saw sequential declines; automotive applications accounted for 88% of full-year sales.
Innovation remained strong, with up to 90 new products launched, including advances in automotive, robotics, and industrial sensor ICs.
Strategic focus on China and India, including local supply chain localization and new entity setup, aims to capture growth in these markets.
Financial highlights
FY 2025 gross margin was 38.6% (EUR 324 million), down from 43.0% in 2024; Q4 gross margin was 38.4%.
Operating income for 2025 was EUR 134 million (16% margin), down 39% year-over-year; Q4 EBIT was EUR 31.5 million (14.7% margin), up 14% year-over-year but down 17% sequentially.
Net debt at year-end stood at EUR 279.7 million; free cash flow for FY 2025 was EUR 97 million.
Dividend proposed for 2025 is EUR 3.70/share (EUR 2.40 final + EUR 1.30 interim).
CAPEX for 2025 was EUR 32.4 million; 2026 CAPEX expected at EUR 40 million.
Outlook and guidance
Sales in H1 2026 expected to be flat year-over-year; H2 2026 anticipated to grow versus H1, mirroring 2025 dynamics.
Gross margin for H1 2026 guided around 40%, operating margin around 17%, with EUR/USD at 1.17 assumed.
Price erosion expected at mid-single digits in 2026, but product mix to offset some of the impact.
Non-automotive business volatility and customer supplier alternation to impact 2026 revenue.
Sales and margin guidance for 2026 are based on stable EUR/USD exchange rates and market conditions.
Latest events from Melexis
- Q1 2026 sales grew 2%, margins improved, and outlook remains stable with strong shareholder returns.MELE
Q1 202629 Apr 2026 - Accelerated innovation, market expansion, and robust financial targets drive future growth.MELE
CMD 20253 Feb 2026 - Q2 2024 sales up 4% year-over-year, with strong margins and lower CAPEX guidance.MELE
Q2 20242 Feb 2026 - Q3 sales steady at €247.9M, but full-year outlook cut amid inventory and market headwinds.MELE
Q3 202417 Jan 2026 - Q1 2025 sales dropped 18% year-over-year, with margins pressured and China strategy advancing.MELE
Q1 202524 Dec 2025 - 2024 sales and profits declined, but innovation and design wins support a mid-2025 recovery.MELE
Q4 202416 Dec 2025 - Q3 sales reached €215.3M, down 13% year-over-year, with gross margin at 38.8%.MELE
Q3 202529 Oct 2025 - Sequential sales and margin growth in Q2 2025, with full-year outlook reaffirmed.MELE
Q2 202530 Jul 2025